Trial Profile
Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of NVP-1203 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs Aceclofenac/eperisone (Primary)
- Indications Back pain
- Focus Pharmacokinetics
- Sponsors Navipharm
- 06 Mar 2019 Status changed from not yet recruiting to completed.
- 20 Sep 2018 Planned number of patients changed from 42 to 38.
- 20 Sep 2018 Planned End Date changed from 1 Dec 2017 to 1 Jul 2019.